Clear Street Markets LLC Amgen Inc Put Options Transaction History

Clear Street Markets LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $3.14 Million - $3.54 Million	14,000 New	14,000 $3.16 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $1.27 Million - $1.41 Million	-5,800 Reduced 96.67%	200 $48,000
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $1.19 Million - $1.36 Million	5,980 Added 29900.0%	6,000 $1.35 Million
Q4 2020 Feb 25, 2021	SELL	$216.38 - $257.67 $2,163 - $2,576	-10 Reduced 33.33%	20 $4,000
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $4,693 - $5,219	-20 Reduced 40.0%	30 $762,000
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $2,611 - $3,129	15 Added 42.86%	50 $968,000
Q4 2018 Jan 23, 2019	SELL	$178.4 - $208.25 $25,154 - $29,363	-141 Reduced 80.11%	35 $681,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $29,819 - $34,848	176 New	176 $3 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.